3649 results for «480»

Filter By

3649 results

Calcified left main lesion PCI

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.

Calcified left main lesion PCI

Complex distal left main bifurcation lesion

04 Jul 2019 – From AICT-AsiaPCR 2019

A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…

Complex distal left main bifurcation lesion

AICT-AsiaPCR Opening Ceremony

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations. 

AICT-AsiaPCR Opening Ceremony

LAD/D1 bifurcation disease

06 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover the key clinical data and angiographic reference of a patient presenting with LAD/D1 bifurcation disease.

LAD/D1 bifurcation disease

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

SIRONA completes enrollment! A leap in the DCB treatment of femoropopliteal arterial disease

02 Nov 2022

When transfemoral TAVI is not an option: rethinking alternative access strategies

18 Jun 2026

In this article, Ulrich Schäfer explores the evolving landscape of access strategies in transcatheter aortic valve implantation (TAVI). While the transfemoral approach remains the gold standard, a significant proportion of patients are not suitable due to peripheral vascular disease or anatomical constraints.
Drawing on clinical evidence and...

Author

Ulrich Schaefer
Alternative access, if transfemoral is not working
Didn’t find what you were looking for?